Latest News

January 09, 2014
UCSF and Quest Diagnostics, the world's leading provider of diagnostic information services, have formed a collaboration to accelerate the translation of biomedical research into advanced diagnostics in the field of precision medicine.
January 07, 2014
Scientists at the UCSF-affiliated Gladstone Institutes have discovered how the interplay between two proteins in the brain fuels the degradation and death of the class of brain cells, or neurons, that leads to Parkinson’s.
December 11, 2013
Renowned Alzheimer’s researcher and founding president of the UCSF-affiliated Gladstone Institutes, Robert Mahley, MD, PhD, has received a Seeding Drug Discovery Award from the Wellcome Trust.
December 06, 2013
Scientists at the UCSF-affiliated Gladstone Institutes have devised a new molecular sensor that can detect MS at its earliest stages, even before the onset of physical signs.
November 15, 2013
Precision Medicine Pillar No. 3: Clinical Discovery. Researchers are taking vast amounts of patient data, often collected through first-ever clinical studies, and putting it into tools like MS Bioscreen that have a direct impact on patient care.
November 04, 2013
UCSF, a world-renowned center for the treatment of movement disorders, is holding an event to celebrate the program’s recognition by the Bachmann-Strauss Foundation as one of three new Centers of Excellence in the field.
October 22, 2013
Lennart Mucke, MD, who directs neurological research at the Gladstone Institutes, next week will receive the ARCS Foundation’s 2013 Pacesetter Award.
October 22, 2013
The National Institutes of Health is awarding $18.8 million, administered through UCSF, to support worldwide research on concussion and traumatic brain injury.
October 18, 2013
The UCSF-affiliated Ernest Gallo Clinic and Research Center has issued a second round of grants to accelerate the discovery and development of new medications to treat alcohol and substance abuse in the context of post-traumatic stress and combat injury.
October 14, 2013
Through support from the Catalyst Awards, UCSF researcher Aditi Bhargava is working to develop a method for delivering small-molecules to a specific target group of cells for treatment of pain.

Pages